BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $636,000 | -88.8% | 640,000 | -85.1% | 0.06% | -89.8% |
Q2 2020 | $5,658,000 | +20.6% | 4,290,000 | -2.2% | 0.58% | +4.1% |
Q1 2020 | $4,690,000 | -5.7% | 4,385,000 | -4.7% | 0.56% | +18.3% |
Q4 2019 | $4,976,000 | +3.9% | 4,600,000 | -1.5% | 0.47% | -5.8% |
Q3 2019 | $4,791,000 | -9.2% | 4,670,000 | -0.7% | 0.50% | -15.4% |
Q2 2019 | $5,279,000 | -3.2% | 4,705,000 | -2.2% | 0.59% | -11.7% |
Q1 2019 | $5,454,000 | -0.3% | 4,810,000 | -1.5% | 0.67% | -15.9% |
Q4 2018 | $5,468,000 | -7.4% | 4,885,000 | -1.3% | 0.79% | -2.7% |
Q3 2018 | $5,908,000 | +0.4% | 4,950,000 | -0.8% | 0.82% | -10.0% |
Q2 2018 | $5,885,000 | -99.9% | 4,990,000 | -2.4% | 0.91% | +0.9% |
Q1 2018 | $5,649,620,000 | -8.0% | 5,115,000 | -0.8% | 0.90% | -8.9% |
Q4 2017 | $6,137,595,000 | -2.8% | 5,155,000 | -1.1% | 0.99% | -9.9% |
Q3 2017 | $6,312,332,000 | +0.3% | 5,210,000 | -1.4% | 1.10% | -7.8% |
Q2 2017 | $6,295,968,000 | +0.9% | 5,285,000 | -0.1% | 1.19% | -1.9% |
Q1 2017 | $6,239,343,000 | -2.7% | 5,290,000 | -2.6% | 1.21% | -8.5% |
Q4 2016 | $6,411,201,000 | -7.4% | 5,430,000 | -1.8% | 1.32% | -8.7% |
Q3 2016 | $6,923,505,000 | +7.6% | 5,530,000 | -1.1% | 1.45% | -1.8% |
Q2 2016 | $6,433,196,000 | -8.7% | 5,590,000 | -0.5% | 1.48% | -12.9% |
Q1 2016 | $7,047,311,000 | +86646.8% | 5,620,000 | -7.3% | 1.70% | -19.8% |
Q4 2015 | $8,124,000 | -13.4% | 6,060,000 | -2.2% | 2.12% | -25.4% |
Q3 2015 | $9,377,000 | – | 6,195,000 | – | 2.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|